616 related articles for article (PubMed ID: 19665429)
1. Inflammation and cancer: how friendly is the relationship for cancer patients?
Aggarwal BB; Gehlot P
Curr Opin Pharmacol; 2009 Aug; 9(4):351-69. PubMed ID: 19665429
[TBL] [Abstract][Full Text] [Related]
2. Multifaceted link between cancer and inflammation.
Sethi G; Shanmugam MK; Ramachandran L; Kumar AP; Tergaonkar V
Biosci Rep; 2012 Feb; 32(1):1-15. PubMed ID: 21981137
[TBL] [Abstract][Full Text] [Related]
3. Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases.
Gupta SC; Kunnumakkara AB; Aggarwal S; Aggarwal BB
Front Immunol; 2018; 9():2160. PubMed ID: 30319623
[TBL] [Abstract][Full Text] [Related]
4. Anti-Inflammatory Drugs as Anticancer Agents.
Zappavigna S; Cossu AM; Grimaldi A; Bocchetti M; Ferraro GA; Nicoletti GF; Filosa R; Caraglia M
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283655
[TBL] [Abstract][Full Text] [Related]
5. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.
Aggarwal BB; Vijayalekshmi RV; Sung B
Clin Cancer Res; 2009 Jan; 15(2):425-30. PubMed ID: 19147746
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms underlying chronic inflammation-associated cancers.
Wu Y; Antony S; Meitzler JL; Doroshow JH
Cancer Lett; 2014 Apr; 345(2):164-73. PubMed ID: 23988267
[TBL] [Abstract][Full Text] [Related]
7. Curcumin targets in inflammation and cancer.
Deguchi A
Endocr Metab Immune Disord Drug Targets; 2015; 15(2):88-96. PubMed ID: 25772169
[TBL] [Abstract][Full Text] [Related]
8. The role of inflammation in skin cancer.
Maru GB; Gandhi K; Ramchandani A; Kumar G
Adv Exp Med Biol; 2014; 816():437-69. PubMed ID: 24818733
[TBL] [Abstract][Full Text] [Related]
9. Molecular link mechanisms between inflammation and cancer.
Vendramini-Costa DB; Carvalho JE
Curr Pharm Des; 2012; 18(26):3831-52. PubMed ID: 22632748
[TBL] [Abstract][Full Text] [Related]
10. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
11. Gene of the month: Interleukin 6 (IL-6).
Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL
J Clin Pathol; 2014 Nov; 67(11):932-7. PubMed ID: 25031389
[TBL] [Abstract][Full Text] [Related]
12. S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.
Rostami N; Nikkhoo A; Ajjoolabady A; Azizi G; Hojjat-Farsangi M; Ghalamfarsa G; Yousefi B; Yousefi M; Jadidi-Niaragh F
Mol Diagn Ther; 2019 Aug; 23(4):467-487. PubMed ID: 31115798
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and cancer: tumor initiation, progression and metastasis, and Chinese botanical medicines.
Weber D; Wheat JM; Curri GM
Zhong Xi Yi Jie He Xue Bao; 2010 Nov; 8(11):1006-13. PubMed ID: 21078262
[TBL] [Abstract][Full Text] [Related]
14. Urolithin A attenuates pro-inflammatory mediator production by suppressing PI3-K/Akt/NF-κB and JNK/AP-1 signaling pathways in lipopolysaccharide-stimulated RAW264 macrophages: Possible involvement of NADPH oxidase-derived reactive oxygen species.
Komatsu W; Kishi H; Yagasaki K; Ohhira S
Eur J Pharmacol; 2018 Aug; 833():411-424. PubMed ID: 29932926
[TBL] [Abstract][Full Text] [Related]
15. Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer.
Yu T; Lao X; Zheng H
Mini Rev Med Chem; 2016; 16(15):1230-1243. PubMed ID: 27145850
[TBL] [Abstract][Full Text] [Related]
16. META060 attenuates TNF-α-activated inflammation, endothelial-monocyte interactions, and matrix metalloproteinase-9 expression, and inhibits NF-κB and AP-1 in THP-1 monocytes.
Desai A; Darland G; Bland JS; Tripp ML; Konda VR
Atherosclerosis; 2012 Jul; 223(1):130-6. PubMed ID: 22658256
[TBL] [Abstract][Full Text] [Related]
17. Tocotrienols: inflammation and cancer.
Nesaretnam K; Meganathan P
Ann N Y Acad Sci; 2011 Jul; 1229():18-22. PubMed ID: 21793834
[TBL] [Abstract][Full Text] [Related]
18. Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer.
Savari S; Vinnakota K; Zhang Y; Sjölander A
World J Gastroenterol; 2014 Jan; 20(4):968-77. PubMed ID: 24574769
[TBL] [Abstract][Full Text] [Related]
19. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?
Aggarwal BB; Kunnumakkara AB; Harikumar KB; Gupta SR; Tharakan ST; Koca C; Dey S; Sung B
Ann N Y Acad Sci; 2009 Aug; 1171():59-76. PubMed ID: 19723038
[TBL] [Abstract][Full Text] [Related]
20. Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products.
Harikumar KB; Sung B; Tharakan ST; Pandey MK; Joy B; Guha S; Krishnan S; Aggarwal BB
Mol Cancer Res; 2010 May; 8(5):751-61. PubMed ID: 20460401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
